chrisvoncsefalvay/vaers-outcomes huggingface dataset:
asymmetrical rash about 5 inches in width and to 4 inches in height around both left and right breast just above the nipples.  Went to Urgent Care for medical treatment.  The doctor advised against future vaccine or second shot
adverse drug reaction; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (adverse drug reaction) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (adverse drug reaction). At the time of the report, VACCINATION COMPLICATION (adverse drug reaction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication were reported. No treatment information was provided by the reporter.
swollen lymph node glands; This is a spontaneous report received from a contactable consumer, the patient. A 21years old non pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number EN6208) via an unspecified route of administration in left arm on 18Mar2021 at 16:15 as a single dose(at the age of 21years) for COVID-19 immunisation. Medical history was not reported. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not allergic to medications, food or other products. Prior to the vaccination, the patient was diagnosed with COVID-19 on an unknown date. Concomitant drugs include LO LOESTRIN FE from an unknown date for unspecified indication. On 20Mar2021 at 12:00, the patient experienced swollen lymph node glands under vaccination arm. The patient was not treated with any medication for the events. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. The clinical outcome of swollen lymph node glands was not recovered at the time of report.   No follow-up attempts are needed. No further information is expected.
Shingles sl; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on 03Apr2021 at 12:00 (at the age of 55-year-old) as a single dose for COVID-19 immunisation. Medical history included food allergy (soy, tomatoes and wheat), allergy to nuts (peanuts) and allergy to metals. The patient checked with her allergist and said that she was not allergic to anything in vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included cetirizine (MANUFACTURER UNKNOWN), rosuvastatin (MANUFACTURER UNKNOWN) and loteprednol etabonate (LOTEMAX) all for unknown indication, from unknown date and unknown if ongoing.  The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021 the patient experienced Shingles. Therapeutic measures were taken as a result of shingles and included treatment with Valacyclovir. Since the vaccination, the patient had not been tested for COVID-19. The event resulted in emergency room/department or urgent care. The clinical outcome of the event Shingles was recovered on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
I had extreme pain in my arm. I couldn't even lift it. It caused my blood pressure to go up. I called the Dr. and Dr. gave me an extra dose of my BP medicine and put me on Ibuprofen. And told me to keep taking these until I started to feel better. It took 2-3 days for pain to go away and for me to get back to normal.
July 2021: Onset of severe GI problems including recurrent abdominal pain, feeling of fluid in abdomen (swollen, jiggly), feel firm spot in low middle of abdomen above pubic bone, stomach upset after eating, stomach upset continue after common allergens removed from diet (all milk and soy including trace ingredients), significant abnormal disturbance of menstrual cycle-- 7 days late; confirmed with home pregnancy test, doctor visit, and ultrasound (8/4/21) that pregnancy had not occurred (also highly unlikely); 8/25/21 oncological gynecologist did endometrium biopsy, PAP and blood work, all normal; continued GI problems, developed blood in stool (black stools), saw GI specialist in 9/2/21 and found blood in stool with lab test.  Had colonoscopy 9/27/21, found and removed 3 small polyps, found to be benign-- blood in stool resolved, GI problems significantly better.
This spontaneous report as received from a pharmacy intern refers to a patient of unknown age and unknown gender. On 26-DEC-2014 the patient was vaccinated with an improperly stored dose of ZOSTAVAX (lot#, Exp and dose/frequency were not provided). No symptoms reported. Additional information has been requested.
received first dose of Shingrix 2 years ago and hasn't receive a second dose yet; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 59-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included SHINGRIX (received 1st dose on unknown date 2 years ago).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: received first dose of Shingrix 2 years ago and hasn't receive a second dose yet).  The outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK receipt date 28 Sep 2023 The pharmacist called to report patient received first dose of Shingrix 2 years ago and had not received a second dose yet. No specific vaccination date or vaccine details reported; only that it was two years ago. The reporter consented to follow up via email. Till the time of reporting the patient did not receive 2nd dose which led to incomplete course of vaccination.
Medication was administered subcutaneous not intramuscular. Cellulitis occurred, site was warm, red, swollen, painful and hard. Was prescribed keflex by ID DR on Saturday, 1/9/2020.  Site continued to grow until Monday, 1/12/2020.
Expired vaccine used; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 77-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Nov-2021 at 4:24 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 18-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 18-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medication were reported.  No treatment medication were reported.  Vaccines were not in the fridge for more than a day unless patients did not appear for their vaccine.
WEAKNESS; This spontaneous report received from a consumer concerned a 52 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: UNKNOWN, and expiry: UNKNOWN) dose was not reported, administered on 10-MAR-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On 11-MAR-2021, the subject experienced weakness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from weakness on 12-MAR-2021. This report was non-serious. This case, from the same reporter is linked to 20210556156, 20210556420 and 20210556823.
I had abdominal pain and diarrhea about two weeks post vaccination. The abdominal pain lasted maybe three days or so. The diarrhea lasted about 3-4 days as well actually. I was also a little fatigued, and that's all I can remember right now. I was self-medicating and did leave work one of the days, I went home sick. I still occasionally have abdominal pain. I contacted the doctor but received no medications or care.
Imms. given at 5:20 PM. Remained in clinic to observe. At 5:25 PM Mom noted redness to Right thigh at injection sites. Examined and found redness and hives covering right upper thigh at injection sites. No other rashes/hives/redness located to entire rest of body. Observed in office. Placed cool cloth and ice to leg. Patient C/O itching to site. Denies any other signs or symptoms. Observed until 6:10 PM when Mom chose to take her home to observe. Declined to take to ER or other medical facility. No PCP. Called this AM and hives remain but no worse. Mom has given 2 doses of BENADRYL. Will continue to monitor and call for changes. To get medical treatment right away for issues.
Pt recvd vax & a few minutes p/vax pt devel hypotension, tachycardia & pruritic non-urticarial rash; sx resolved w/appropriate treatment;
Mom called & stated pt. was feeling very tired after having GARDASIL inj.  No other sx's.  Advised to call if Sx change or worsen.
Tachycardia, unstable blood pressure,Frequent urination, pain in left arm,Chest pain
small area that it hurts to touch and that somedays just hurts by itself; real sore shoulder but is still hurting; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (small area that it hurts to touch and that somedays just hurts by itself) and MYALGIA (real sore shoulder but is still hurting) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 303M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced PAIN (small area that it hurts to touch and that somedays just hurts by itself) and MYALGIA (real sore shoulder but is still hurting). At the time of the report, PAIN (small area that it hurts to touch and that somedays just hurts by itself) and MYALGIA (real sore shoulder but is still hurting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant product use was reported No treatment information was provided
experienced Fatigue,no energy; sore throat; joint pain; This is a spontaneous report from a contactable consumer or other non hcp (Patient) from a Pfizer A female patient of an unspecified age received second dose of bnt162b2 (PFIZER-BIOTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as dose 2, single for covid-19 immunization. No medical history and no concomitant medications were not reported. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 1, on an unspecified date for covid-19 immunization. It was reported that Patient received second dose of Covid vaccine over a month ago but in the last 5 days she has experienced Fatigue, sore throat, joint pain, and no energy. She took Covid test Monday, and it was negative. She is calling to see if this could be side effects this long after taking the vaccine. The patient underwent lab tests and procedures which included sars-cov-2 test: negative. The outcome for the events was reported as unknown at the time of this report.   Information about lot/batch has been requested.  Follow-up attempts are completed. No further information is expected.
Dr. reported to Infection Control Dept of hospital that patient had swelling in his throat after the Moderna shot series that he felt was related to the shot. He complained of hoarseness and SOB and his CT of the neck on 4/9/21 showed : " Mild soft tissue thickening in the left glottis and supraglottic region. Differential possibilities include infection, inflammation, and neoplasm. " Dr. believed that is was inflammation caused by the Moderna vaccine.
1 wk after vaccination noticed redness and increased skin temper. at vaccination site and also on inside of upper arm.
27 and a half hours after injection I experienced injection site pain, nausea, stomach pain, fatigue , weakness, tiredness, low grade fever, hot and cold sweats. These symptoms lasted 2 days.  8 days after injection I found several red rash spots on my arms and torso.
Hard red hot swollen itchy area near injection site which measures 6 1/2" × 4" as of today.
pt recv vax & 30min later devel periorbital edema, hives, & wheezing given DPH & albuterol nebulizer;improve;
swelling of arm, red rash patch , sore , warm to touch ,  light ache to body , flu like feeling,  -  took place almost 9 days after vaccine .  treat with cream for rash , along with over the counter Motrin . lasted nearly 4 days
pt recv vax 23SEP97 & 23SEP97 pt became pregnant;LMP 31AUG97;pregnant confirmed by pregnant test;expected date of delivery 7JUN98;fetus had intrauterine growth retardation, severe fetal bradycardia, anemia, & a tight nuchal cord, hypospadia
GASSY, FUSSY, CRYING, DIARRHEA, VOMITING, POOR EATING.  LASTING ABOUT 2 WEEKS.
This spontaneous reports as received from a health professional refers to a 12 month old patient of unknown gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 13-NOV-2015, the patient was vaccinated with an improperly stored dose of (Oka/Merck) VARIVAX lot # L024256, expiration date: 01-JUL-2017 (exact dose and route of administration were not reported). The temperature excursion of the administered dose of vaccine was 20.3 degrees Fahrenheit for 72 hours. Data logger was involved. There were no previous excursions reported. There was no adverse effect reported. This is one of several reports received from the same reporter. Additional information has been requested.
On Thursday morning, I felt ill and fatigued. I proceeded to faint and then cough up bright red blood. I was taken to the Hospital Emergency Room to be evaluated. There they did a full exam, Blood work, and EKG, and chest x ray. Blood work revealed I had an extremely elevated D-Dimer so I was transferred by ambulance to Hospital for further evaluation. Once there I had a CT scan which showed enlarged lymph nodes but no other conclusions, I was released and told to follow up with a  Cardiologist and Pulmonologist for further evaluation of my symptoms.
Rash around  DTaP / IPV site - size of a quarter, pimple - like bumps - red area - rash started next day- lasted for 5 days- without fever.
symptoms started about 20 hours after vaccine- extreme muscle aches and joint pain to the point movement of any kind was unbearable. Extreme chills, headache, nausea - I took Advil and Tylenol every 4 hours and nothing eased the pain. After all day of suffering I started to vomit and have severe chest and stomach pain and went to local ER.
9 days after receiving the flu shot, the patient had a sudden onset of widespread arthralgia. Gone to dr 11/25-returned 11/27. Erythocyte sedimentation rate 75 Antinuclear antibody - RA -. Pain with range of motion of joints. Symptoms decreased by 12/4/06. Erythrocyte sedimentation rate is decreasing-down to 60.
After giving the Pfizer vaccine, were notified that the vaccine had experienced a temperature monitoring event outside of our facility.  The patient and his family were called and informed of the CDC recommendations.  The patient came in to receive an addition vaccine on 10/18/22.
Information has been received from a physician concerning a female who was vaccinated with the second dose of Gardasil and then missing her menstrual cycle the following month. Medical attention was sought. Additional information has been requested. This is in follow-up to report(s) previously submitted on 8/14/2007. Initial and follow-up information has been received from a physician and a registered nurse practitioner concerning a 15 year old female student, with no pertinent medical history, who on 10-NOV-2006 at 11:06 am, was vaccinated IM in the right hip with a first dose of GARDASIL (lot # 653736/0868F). On 12-JAN-2007 at 17:35, the patient was vaccinated IM in the left arm with a second dose of GARDASIL (lot # 655165/1425P). On 11-MAY-2007 at 16:07, the patient was vaccinated IM in the right arm with a first dose of GARDASIL (lot # 653726/0868F). Concomitant medication included hormonal contraceptives (unspecified). On 13-JUL-2007, the patient missed her menstrual period (also reported as skipping her menstrual period after the first two vaccines). It was also reported at the same time the patient stopped taking hormonal contraceptives (unspecified). The patients menstrual period resumed the following month. At the time of the report, the status of the patient was unknown. Additional information is not expected.
Swelling of throat and extensive cough. At 6:00 PM total fatigue, shivers. By 7:00 PM red face, red eyes and by 7:30 PM fever of 102. Extremely strong pain in all joints  Very weak and almost unable to walk. At 9:45PM took two Tylenol and the temp went down to 101.2. Went to bed and the next morning temp. was down to 99. Felt still very weak and had a lot of joint pain. Took two Aleve. In the evening started feeling better. The whole experience was very scary and I will never get the high dose of the Flu vaccine again.
Tiredness; This is a spontaneous report from a non-contactable consumer. This female consumer reported that.  An unspecified age adult female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on Feb2021 as single dose, dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for COVID-19 immunisation.The patient medical history and concomitant medications were not reported. It was Unknown if patient received other vaccine in four weeks and Other medications in two weeks. It was reported that it was unknown if patient was pregnant at the time of vaccination. The patient experienced tiredness on Feb2021. The outcome of event was unknown.  No follow-up attempts are possible. Information about lot/Batch number cannot be obtained.
UrticariaPruritus itching at injection site and swollen lymph nodes Narrative:
SARS COV-19 Infection. Cough, Congestion, Runny Nose, Fever, Loss of Taste and smell, Headache, Shortness of Breath, Sore Throat, Fatigue, Chills, Muscle Aches
IgA vasculitis, manifesting as symptoms of rash and abdominal pain, currently significantly improved on prednisone taper
PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE ADULT OBSTRUCTIVE SLEEP APNEA, SEVERE
w/in 8hr devel fever, vomiting, h/a later 23hr;2 day devel severe lt arm pain which cont now;day 7 arm is not tender;
Chest pain, arrhythmias, Shortness of breath, Unusual headaches, urinary changes
Throat Swelling internally,   Stiff neck,  Trouble swallowing,  Facial numbness, Rapid heart, tight chest
Patient became unresponsive outside the building  after receiving vaccine.  Patient became visibly pale, diaphoretic and cyanotic. Event lasted about 30 seconds but repeated two more times until EMS arrived.
Nodules formed in my lymphnodes on the left side of my body.  The first appeared two days after the first injection below my left clavical, the second appeared the day of my second injection above my left clavical - both nodules are still present six months later, are not iverly hard, and moveable.  An ultrasound was performed and I was told that they look like "normal" lymph nodes though you can feel the knots and they could be seen on the ultrasound screen.  Additionally, in July, we were exposed to "something" (we think the Delta variant), even though we were all vaccinated and masked, and had a breakthrough that put us on our backs for a week.   Notified my doctors office of symptoms, didn't get in to see her until End of August. Since then I have had numbness in my left hand/ arm, phantom smells, loss of or disgusting tastes, brain fog, and the list goes on and on.  I've had an EMG to determine the cause of the nerve damage (it's muscle wasting in the entire appendage), but due to teh status of the overwhelmed healthcare system have received no definative diagnosis.
This spontaneous report as received from a consumer (who was the patients' mother and grandmother) refers to 2 male patients of unknown age. No information regarding the patients' medical history or concurrent conditions was provided. On unknown dates, the patients were vaccinated with doses of an unspecified human papillomavirus vaccine (manufacturer unknown) injection (dose and route of administration were not reported). There were no concomitant therapies reported. On unknown dates, the patients were both diagnosed with meningitis. The outcome of the event was not reported. The relatedness between the unspecified human papillomavirus vaccine (manufacturer unknown) and the event was not provided. Upon internal review, the event of meningitis was considered to be medically significant. Additional information is not expected as the reporter refused to provide any contact details.
Excessive bruising, fatigue, slowed clotting. Petechial bruising/spotting.
Information has been received from a physician and a practice manager via company representative referring to a patient of unknown age and gender. On 18-MAR-2015 the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23-10PK-0.5mlSD-PFS-LLowkwTip) (lot # K019386, expiration date 09-JUN-2016). This specified lot number vaccine was exposed to temperature excursion once. The total cumulative excursion time was 216 hours with the lowest recorded temperature of 27 Fahrenheit degree. The storage criteria and the type of excursion for this vaccine was refrigerator (R). No adverse effect was reported. This is one of several reports received from the same source. Additional information has been requested.